Home Courts Regeneron sues U.S. to stop Medicare drug pricing rule

Regeneron sues U.S. to stop Medicare drug pricing rule

SHARE

Trump has called the new rule “groundbreaking” and declared that it will “transform the way the U.S. government pays for drugs.”
Regeneron argues that price controls will discourage investments in new drugs and could lead to drug shortages.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email